The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs

Today, a combination of globalization of pharmaceutical production, lack of regulatory harmonization, and weakness of Medicines Regulatory Authorities, creates the “perfect conditions” for poor-quality medicine to circulate in the global market and to penetrate the less-regulated countries. Medicines regulation is the responsibility of the national regulatory authorities in the recipient country, but in the poorer countries, in practice, the responsibility of supply of quality-assured medicines is often taken by Non-Governmental Organizations and other implementers. But with some notable excep... Mehr ...

Verfasser: Raffaella Ravinetto
Tim Roosen
Catherine Dujardin
Dokumenttyp: Artikel
Erscheinungsdatum: 2018
Reihe/Periodikum: Journal of Pharmaceutical Policy and Practice, Vol 11, Iss 1 (2018)
Verlag/Hrsg.: Taylor & Francis Group
Schlagwörter: quality of medicines / quality assurance / belgium / low-income countries / capacity-building / pharmaceutical policy / supply / Therapeutics. Pharmacology / RM1-950 / Pharmacy and materia medica / RS1-441
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28531550
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.1186/s40545-018-0136-z